Advertisement
New Zealand markets closed

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NZD/USD

    0.5936
    -0.0001 (-0.01%)
     

  • NZD/EUR

    0.5543
    -0.0003 (-0.05%)
     

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • OIL

    82.81
    0.00 (0.00%)
     

  • GOLD

    2,329.10
    -9.30 (-0.40%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • NZD/JPY

    92.1320
    +0.0170 (+0.02%)
     

Global Antibody Therapy Market Research Report 2022: Analysis & Forecasts, 2014-2021 & 2022-2032: mAbs, Oncology, Autoimmune, Infectious Diseases, Antibody-drug Conjugates ADCs

Research and Markets
·4-min read
Company Logo
Company Logo

Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Antibody Therapy Market" report has been added to ResearchAndMarkets.com's offering.

A recent market study on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics.

After conducting thorough research on the historical and current growth parameters of the Antibody Therapy Market, the growth prospects of the market are obtained with maximum precision.

The Antibody Therapy Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
Key Topics Covered:


1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations

2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations

3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Antibody Therapy Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points
4.1. Global Protective Coatings Market (US$ Mn)
4.2. Antibody Therapy Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Protective Coatings Market Growth
4.5.3. Antibody Therapy Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Antibody Therapy Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors
5.1. Manufacturers' Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6. Global Antibody Therapy Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis

7. Global Antibody Therapy Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8. Global Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By Type
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Type, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2032
8.3.1. Monoclonal Antibodies (mAbs)
8.3.1.1. Oncology
8.3.1.2. Autoimmune Diseases
8.3.1.3. Infectious Diseases
8.3.1.4. Others
8.3.2. Antibody-drug Conjugates (ADCs)
8.4. Market Attractiveness Analysis By Type

9. Global Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By End-use
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By End-use, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032
9.3.1. Hospitals
9.3.2. Specialty Centers
9.3.3. Others
9.4. Market Attractiveness Analysis By End-use

10. Global Antibody Therapy Market Analysis 2015-2021 and Forecast 2022-2032, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
10.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

Competition Analysis

  • Bristol-Myers Squibb

  • GlaxoSmithKline plc

  • Takeda Pharmaceuticals

  • Eli Lilly and Company

  • Merck & Co Inc.

  • Seagen

  • Johnson & Johnson

  • Novartis AG

  • Regeneron Pharmaceuticals

  • F. Hoffmann-La Roche Ltd.

  • Merck & Co Incseagen.

ADVERTISEMENT

For more information about this report visit https://www.researchandmarkets.com/r/dv5i31

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900